The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Cladribine For Treating Neuromyelitis Optica - EP3099307

The patent EP3099307 was granted to Chord Therapeutics on Jul 29, 2020. The application was filed on Jan 27, 2015 under application number EP15702549A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3099307

CHORD THERAPEUTICS
Application Number
EP15702549A
Filing Date
Jan 27, 2015
Status
Patent Maintained As Amended
Jun 26, 2020
Publication Date
Jul 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MERCK PATENTJul 18, 2018- -

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0173059
DESCRIPTIONEP2263678
DESCRIPTIONUS5208327
DESCRIPTIONUS5506214
DESCRIPTIONWO2004087100
INTERNATIONAL-SEARCH-REPORTEP2263678
INTERNATIONAL-SEARCH-REPORTUS2010092478
OPPOSITIONUS2010239580
OPPOSITIONWO2004087100
OPPOSITIONWO2006067141
OPPOSITIONWO2008097596
OPPOSITIONWO2011080344

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents